Supernus Pharmaceuticals Inc (SUPN)

Supernus Pharmaceuticals Inc (SUPN) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $2.4B; returns 1 day -3.3%, 1 week +7.4%, 1 year -21.8%.

Supernus Pharmaceuticals Inc. is a biopharmaceutical company primarily focused on the development and commercialization of products for Central Nervous System (CNS) diseases, encompassing both neurological and psychiatric disorders.

Groups SUPN belongs to

• Biotechnology
• Pharmaceuticals
• CNS Disorders
• Healthcare
• Biopharmaceutical
• Commercial Stage Biotech
• Neurological Disorders
• Mental Health Solutions
• Talk Therapy and Psychiatry
• Women's Health

SUPN financial model: income statement, cash flow and balance sheet